OCULAR EFFECTS OF A N,N-DISUBSTITUTED 5-OH AMINOTETRALIN (N-0437) - EVIDENCE FOR A DUAL MECHANISM OF ACTION

被引:13
作者
CROSSON, CE
BURKE, JA
CHAN, MF
POTTER, DE
机构
[1] ALLERGAN INC,DEPT PHARMACOL,DISCOVERY RES,IRVINE,CA 92715
[2] UNIV CALIF IRVINE,DEPT OPHTHALMOL,IRVINE,CA 92717
关键词
D O I
10.3109/02713688708997557
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
引用
收藏
页码:1319 / 1326
页数:8
相关论文
共 20 条
[1]   N,N-DISUBSTITUTED 2-AMINOTETRALINS ARE POTENT D-2 DOPAMINE RECEPTOR AGONISTS [J].
BEAULIEU, M ;
ITOH, Y ;
TEPPER, P ;
HORN, AS ;
KEBABIAN, JW .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 105 (1-2) :15-21
[2]   OCULAR EFFECTS OF A RELATIVELY SELECTIVE ALPHA-2 AGONIST (UK-14, 304-18) IN CATS, RABBITS AND MONKEYS [J].
BURKE, JA ;
POTTER, DE .
CURRENT EYE RESEARCH, 1986, 5 (09) :665-676
[3]   SYNTHESIS AND RADIORECEPTOR BINDING-ACTIVITY OF N-0437, A NEW, EXTREMELY POTENT AND SELECTIVE D2 DOPAMINE RECEPTOR AGONIST [J].
HORN, AS ;
TEPPER, P ;
VANDERWEIDE, J ;
WATANABE, M ;
GRIGORIADIS, D ;
SEEMAN, P .
PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION, 1985, 7 (05) :208-211
[4]  
JENNEWEIN HM, 1986, EUR J PHARMACOL, V123, P363
[5]  
LUSTIG A, 1983, DEUT MED WOCHENSCHR, V108, P1656
[6]  
MEKKI QA, 1984, LANCET, V1, P287
[7]  
MEKKI QA, 1983, LANCET, V1, P1250
[8]   STIMULATION OF DOPAMINE-RECEPTORS (TYPE-2) LOWERS HUMAN INTRAOCULAR-PRESSURE [J].
MEKKI, QA ;
TURNER, P .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1985, 69 (12) :909-910
[9]  
Potter D E, 1985, J Ocul Pharmacol, V1, P29, DOI 10.1089/jop.1985.1.29
[10]  
POTTER D E, 1986, Investigative Ophthalmology and Visual Science, V27, P289